NEW YORK (GenomeWeb News) — Roche e today said it has sold a 454 Life Sciences GS20 sequencer to the South African company Inqaba Biotechnical Industries. The deal includes the option to upgrade to a GS FLX.
 
Roche Diagnostics said it will provide Inqaba with support for the GS20’s applications.  
 
Inqaba said it was supported by BioPAD, a South African government-funded trust and shareholder designed to create a sequencing service in the region.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.